A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesis.

PLoS One · 2021 · PMC8172048 · PMID 34077449

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantp-value <0.01actually significant

The inhibition of tumor-induced NV observed in the combination group was highly significant compared to the tumor control group and both monotherapy control groups across all experiments (p-value <0.01).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.